FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
Juvena lands $33.5m to advance more regenerative biologics to the clinic
Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs…
A Game Changer for IBD Care: The Advantages of Intestinal Ultrasound
By: Lisette Hilton | January 06, 2026 | 5 min. read | Share Intestinal ultrasound allows trained physicians to…
Short bursts of oxygen deprivation could help treat depression: Chinese study
Brief, controlled bouts of oxygen deprivation – essentially moments of safe suffocation – can alleviate severe depression as…
Freya Pharma Solutions Rebrands as Arletta Pharma
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta…
EU Reform Aims to Fast-Track Cancer Drug Access
At the European Society for Medical Oncology (ESMO) Annual Meeting 2025, held recently in Berlin, experts presented an…
FDA approves new menopause drug without hormones. Here’s what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
Common opioid is not that effective for easing chronic pain, study finds
Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICO
Joint debt: Let’s see Draghi has been a consistent advocate for EU joint borrowing of the kind carried…
Life Bio: epigenetic rejuvenation ‘transcends organs’
Longevity biotech presents data demonstrating therapeutic impact of partial epigenetic reprogramming across multiple biological systems. Today at the…